Cargando…
Postvaccine Myocarditis: A Risk Worth the Reward?
Autores principales: | Raman, Betty, Neubauer, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radiological Society of North America
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855313/ https://www.ncbi.nlm.nih.gov/pubmed/35166589 http://dx.doi.org/10.1148/radiol.220252 |
Ejemplares similares
-
Postvaccine myocarditis and the use of antipyretics: Is there any relation?
por: Fatima, Maurish, et al.
Publicado: (2023) -
COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance?
por: Samuel, Samson Mathews, et al.
Publicado: (2022) -
Unraveling the Mystery of COVID-19 Postvaccination Myocarditis: A Systematic Review of Current Cases
por: Ghoshouni, Hamed, et al.
Publicado: (2022) -
Risk versus reward: is this stock really worth it?
por: Kahn, Michael N, et al.
Publicado: (2011) -
Lung biopsy in ARDS: is it worth the risk?
por: Malhotra, Atul, et al.
Publicado: (2006)